Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 1
2014 1
2020 1
2021 3
2022 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Serrated polyps: innocent or guilty?
Mansilla-Vivar R, Petruzzellis C, Olivari N, Milluzzo SM, Grassano A, Cesari P, Zorzi F, Spada C. Mansilla-Vivar R, et al. Among authors: petruzzellis c. Rev Gastroenterol Peru. 2021 Oct-Dec;41(4):245-253. Rev Gastroenterol Peru. 2021. PMID: 35613395 English.
Probiotics: which and when?
Scarpellini E, Cazzato A, Lauritano C, Gabrielli M, Lupascu A, Gerardino L, Abenavoli L, Petruzzellis C, Gasbarrini G, Gasbarrini A. Scarpellini E, et al. Among authors: petruzzellis c. Dig Dis. 2008;26(2):175-82. doi: 10.1159/000116776. Epub 2008 Apr 21. Dig Dis. 2008. PMID: 18431068 Review.
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.
Pugliese D, Privitera G, Crispino F, Mezzina N, Castiglione F, Fiorino G, Laterza L, Viola A, Bertani L, Caprioli F, Cappello M, Barberio B, Ricci C, Balestrieri P, Daperno M, Pluchino D, Rizzello F, Scribano ML, Sablich R, Pastorelli L, Manguso F, Variola A, Di Sario A, Grossi L, Armuzzi A; IG‐IBD LIVE Study Group. Pugliese D, et al. Aliment Pharmacol Ther. 2022 Jul;56(1):95-109. doi: 10.1111/apt.16923. Epub 2022 May 12. Aliment Pharmacol Ther. 2022. PMID: 35876062 Free PMC article.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.
Nardone OM, Marasco G, Lopetuso LR, Mocci G, Pastorelli L, Petruzzellis C, Scaldaferri F, On Behalf Of The Italian Association Of Young Gastroenterologist And Endoscopist Aggei. Nardone OM, et al. Among authors: petruzzellis c. J Clin Med. 2023 Mar 2;12(5):2005. doi: 10.3390/jcm12052005. J Clin Med. 2023. PMID: 36902792 Free PMC article.
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study.
Furnari M, Eusebi LH, Savarino E, Petruzzellis C, Esposito G, Maida M, Ricciardiello L, Pecere S, Buda A, De Bona M, Spada C, Di Giulio E, Costamagna G, Boskoski I, Giannini EG; Young-ENDO-ITA Study Group. Furnari M, et al. Among authors: petruzzellis c. Gut. 2021 Jul;70(7):1241-1243. doi: 10.1136/gutjnl-2020-323116. Epub 2020 Sep 28. Gut. 2021. PMID: 32989018 No abstract available.